Evidence map›Paper›PMID 37477361›Full record

Trial reportInflammatory bowel diseases2024

Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress.

Daniel Romano, Susan Chesterman, Matthew Fuller-Tyszkiewicz, Subhadra Evans, Madeleine Dober, Richard Gearry, Peter R Gibson, Simon Knowles, Andrew McCombie, Eric O and 4 more

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Inflammatory bowel diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Daniel RomanoSchool of Psychology, Deakin University, Geelong, Victoria, Australia.ORCID 0000-0002-4213-9831
Susan ChestermanSchool of Psychology, Deakin University, Geelong, Victoria, Australia.
Matthew Fuller-TyszkiewiczSchool of Psychology, Deakin University, Geelong, Victoria, Australia.
Subhadra EvansSchool of Psychology, Deakin University, Geelong, Victoria, Australia.
Madeleine DoberSchool of Psychology, Deakin University, Geelong, Victoria, Australia.
Richard GearryDepartment of Medicine, Christchurch School of Medicine and Health Sciences, Univeresity of Otago, Christchurch, New Zealand.
Peter R GibsonDepartment of Gastroenterology, Alfred Health, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Simon KnowlesSchool of Health Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
Andrew McCombieDepartment of General Surgery, Te Whatu Ora Ōtautahi (Health New Zealand Christchurch), Christchurch, New Zealand.
Eric OFaculty of Health, Deakin University, Burwood, Victoria, Australia.
Lisa OliveSchool of Psychology, Deakin University, Geelong, Victoria, Australia.
Leanne RavenCrohn's and Colitis Australia, Camberwell, Victoria, Australia.
Leesa Van NiekerkSchool of Psychological Sciences, University of Tasmania, Hobart, Tasmania, Australia.ORCID 0000-0002-6641-5888
Antonina Mikocka-WalusSchool of Psychology, Deakin University, Geelong, Victoria, Australia.ORCID 0000-0003-4864-3956
Deakin University · AUAlfred Health · AUCrohn's & Colitis Australia · AUSwinburne University of Technology · AUUniversity of Otago · NZUniversity of Tasmania · AU

Funding

Crohn's and Colitis Foundation of America #828660Litwin IBD Pioneers #828660
6 · The paper itself

Abstract

backgroundThe bidirectional relationship between inflammatory bowel disease (IBD) flare-ups and depression/anxiety symptoms has prompted investigations into psychotherapy to improve health-related quality of life (HRQoL) by targeting depression and anxiety. Acceptance commitment therapy (ACT) is effective in improving symptoms of depression and anxiety in people with chronic diseases, yet minimal research has examined ACT's effectiveness for IBD. This study examines the feasibility, acceptability, and preliminary efficacy of the ACTforIBD program, an online program codesigned with consumers to deliver ACT to those with IBD.

methodsAdults with IBD and symptoms of mild-moderate distress were randomized to ACTforIBD or an active control (psychoeducation) condition. Participants completed 8 weekly, 1-hour sessions, 4 of which were therapist facilitated. Feasibility was based on recruitment and retention and acceptability was derived from postprogram satisfaction measures. Preliminary efficacy was determined by group differences in rate of change in study outcomes from baseline to postprogram.

resultsOf 62 participants (89% women, 11% men; mean age  33 years), 55 completed the program (ACTforIBD: n = 26 [83.9%]; active control: n = 29 [93.5%]). Adherence and acceptability were high in the ACTforIBD group, with 80% of participants completing all self-directed modules and 78% of participants expressing satisfaction with the program. Significant and marginally significant group × time interactions were found for anxiety symptoms (b = -1.89; 95% confidence interval, -3.38 to -0.42) and psychological HRQoL (b = -0.04; 95% confidence interval, -0.07 to 0.01), showing decreased anxiety and increased psychological HRQoL in the intervention group.

conclusionsACTforIBD is feasible, acceptable, and improved anxiety symptoms, and psychological HRQoL. This highlights the need for a full-scale randomized controlled trial to further examine the program's efficacy.

Indexed as

Acceptance and Commitment TherapyAnxietyDepressionFeasibility StudiesInflammatory Bowel DiseasesQuality of LifeAdultFemaleHumansMaleMiddle AgedPatient Acceptance of Health CarePsychological DistressTreatment Outcomeacceptance commitment therapydistressfeasibilitypreliminary efficacyrandomized controlled trial

Identifiers

PMID37477361
PMCPMC11144983
OpenAlexW4384924795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.